Protective effects of chronic resveratrol treatment on vascular inflammatory injury in streptozotocin-induced type 2 diabetic rats: Role of NF-kappa B signaling

European Journal of Pharmacology

Volumn 720, Issue 1-3, 2013, Pages 147-157

  Zheng, Xiaoying ^a   Zhu, Shenyin ^a   Chang, Shufang ^a   Cao, Yanni ^a   Dong, Jie ^a   Li, Juan ^a   Long, Rui ^a   Zhou, Yuanda ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Inflammation; NF kappa B; Resveratrol; Type 2 diabetes; Vascular injury

Indexed keywords

CHOLESTEROL; GLUCOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MONOCYTE CHEMOTACTIC PROTEIN 1; NUCLEOPROTEIN; RESVERATROL; SMALL INTERFERING RNA; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD VESSEL INJURY; BLOOD VESSEL PERMEABILITY; CAROTID ARTERY INJURY; CONTROLLED STUDY; DIABETIC ANGIOPATHY; DISORDERS OF LIPID METABOLISM; DOWN REGULATION; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; DRUG STRUCTURE; ENDOTHELIUM CELL; GLUCOSE METABOLISM; HUMAN; HUMAN CELL; INSULIN RESISTANCE; LIPID METABOLISM; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; THORAX INJURY; UPREGULATION; VASCULAR DISEASE;

ANIMALS; AORTA, THORACIC; CAPILLARY PERMEABILITY; CAROTID ARTERIES; CAROTID ARTERY INJURIES; CELL LINE; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DIET, HIGH-FAT; ENDOTHELIAL CELLS; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INTERLEUKIN-1BETA; INTERLEUKIN-6; LIPIDS; MALE; NF-KAPPA B; RATS; RATS, SPRAGUE-DAWLEY; STILBENES;

EID: 84890128149     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2013.10.034     Document Type: Article

References (40)

1. D.M. Arrick, H. Sun, K.P. Patel, and W.G. Mayhan Chronic resveratrol treatment restores vascular responsiveness of cerebral arterioles in type 1 diabetic rats Am. J. Physiol. Heart Circ. Physiol. 301 2011 H696 703
2. J.A. Baur, and D.A. Sinclair Therapeutic potential of resveratrol: the in vivo evidence Nat. Rev. Drug Discov. 5 2006 493 506 (Pubitemid 44136961)
3. L. Boring, J. Gosling, M. Cleary, and I.F. Charo Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis Nature 394 1998 894 897 (Pubitemid 28410911)
4. A. Borriello, V. Cucciolla, F. Della Ragione, and P. Galletti Dietary polyphenols: focus on resveratrol, a promising agent in the prevention of cardiovascular diseases and control of glucose homeostasis Nutr. Metab. Cardiovasc. Dis. 20 2010 618 625
5. A.P. Burke, F.D. Kolodgie, A. Zieske, D.R. Fowler, D.K. Weber, P.J. Varghese, A. Farb, and R. Virmani Morphologic findings of coronary atherosclerotic plaques in diabetics: a postmortem study Arterioscler. Thromb. Vasc. Biol. 24 2004 1266 1271 (Pubitemid 38880019)
6. N. Clausell, V.C. de Lima, S. Molossi, P. Liu, E. Turley, A.I. Gotlieb, A.G. Adelman, and M. Rabinovitch Expression of tumour necrosis factor alpha and accumulation of fibronectin in coronary artery restenotic lesions retrieved by atherectomy Br. Heart J. 73 1995 534 539
7. A. Csiszar, N. Labinskyy, A. Podlutsky, P.M. Kaminski, M.S. Wolin, C. Zhang, P. Mukhopadhyay, P. Pacher, F. Hu, R. de Cabo, P. Ballabh, and Z. Ungvari Vasoprotective effects of resveratrol and SIRT1: attenuation of cigarette smoke-induced oxidative stress and proinflammatory phenotypic alterations Am. J. Physiol. Heart Circ. Physiol. 294 2008 H2721 2735
8. A. Csiszar, P. Pacher, G. Kaley, and Z. Ungvari Role of oxidative and nitrosative stress, longevity genes and poly(ADP-ribose) polymerase in cardiovascular dysfunction associated with aging Curr. Vasc. Pharmacol. 3 2005 285 291 (Pubitemid 40933050)
9. A. Csiszar, K. Smith, N. Labinskyy, Z. Orosz, A. Rivera, and Z. Ungvari Resveratrol attenuates TNF-alpha-induced activation of coronary arterial endothelial cells: role of NF-kappaB inhibition Am. J. Physiol. Heart Circ. Physiol. 291 2006 H1694 1699
10. M.I. Cybulsky, and M.A. Gimbrone Jr. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis Science 251 1991 788 791
11. D. de Zeeuw, and S.J.L. Bakker Does the metabolic syndrome add to the diagnosis and treatment of cardiovascular disease? Nat. Clin. Pract. Cardiovasc. Med. 5 2008 S10-S14
12. S. Demirbilek, M. Akin, K. Gurunluoglu, N.E. Aydin, M.H. Emre, E. Tas, R.T. Aksoy, and S. Ay The NF-kappaB inhibitors attenuate hepatic injury in bile duct ligated rats Pediatr. Surg. Int. 22 2006 655 663 (Pubitemid 44378710)
13. E. Fan, L. Zhang, S. Jiang, and Y. Bai Beneficial effects of resveratrol on atherosclerosis J. Med. Food 11 2008 610 614
14. M.G. Farb, S. Bigornia, M. Mott, K. Tanriverdi, K.M. Morin, J.E. Freedman, L. Joseph, D.T. Hess, C.M. Apovian, J.A. Vita, and N. Gokce Reduced adipose tissue inflammation represents an intermediate cardiometabolic phenotype in obesity J. Am. Coll. Cardiol. 58 2011 232 237
15. J. Fu, C.P. Liu, Z.W. Zhang, M.W. Xing, and S.W. Xu Influence of inflammatory pathway markers on oxidative stress induced by cold stress in intestine of quails Res. Vet. Sci 2013
16. S.D. Funk, A. Yurdagul Jr., and A.W. Orr Hyperglycemia and endothelial dysfunction in atherosclerosis: lessons from type 1 diabetes Int. J. Vasc. Med. 2012 2012 569654
17. D.M. Goldberg, J. Yan, and G.J. Soleas Absorption of three wine-related polyphenols in three different matrices by healthy subjects Clin. Biochem. 36 2003 79 87 (Pubitemid 36126394)
18. N. Hancu, M.G. Netea, and I. Baciu High glucose concentrations increase the tumor necrosis factor-alpha production capacity by human peripheral blood mononuclear cells Rom. J. Physiol. 35 1998 325 330
19. M. Hashizume, and M. Mihara Atherogenic effects of TNF-alpha and IL-6 via up-regulation of scavenger receptors Cytokine 58 2012 424 430
20. R.R. Holman, S.K. Paul, M.A. Bethel, D.R. Matthews, and H.A. Neil 10-year follow-up of intensive glucose control in type 2 diabetes N. Engl. J. Med. 359 2008 1577 1589
21. S.K. Jain, J. Rains, J. Croad, B. Larson, and K. Jones Curcumin supplementation lowers TNF-alpha, IL-6, IL-8, and MCP-1 secretion in high glucose-treated cultured monocytes and blood levels of TNF-alpha, IL-6, MCP-1, glucose, and glycosylated hemoglobin in diabetic rats Antioxid. Redox Signal. 11 2009 241 249
22. Y.H. Jing, K.H. Chen, S.H. Yang, P.C. Kuo, and J.K. Chen Resveratrol ameliorates vasculopathy in STZ-induced diabetic rats: role of AGE-RAGE signaling Diabetes Metab. Res. Rev. 26 2010 212 222
23. M.Y. Kim, J.H. Lim, H.H. Youn, Y.A. Hong, K.S. Yang, H.S. Park, S. Chung, S.H. Ko, S.J. Shin, B.S. Choi, H.W. Kim, Y.S. Kim, J.H. Lee, Y.S. Chang, and C.W. Park Resveratrol prevents renal lipotoxicity and inhibits mesangial cell glucotoxicity in a manner dependent on the AMPK-SIRT1-PGC1alpha axis in db/db mice Diabetologia 56 2012 204 217
24. C. Morais, B. Pat, G. Gobe, D.W. Johnson, and H. Healy Pyrrolidine dithiocarbamate exerts anti-proliferative and pro-apoptotic effects in renal cell carcinoma cell lines Nephrol. Dial. Transplant. 21 2006 3377 3388 (Pubitemid 44817085)
25. R. Natarajan, and J.L. Nadler Lipid inflammatory mediators in diabetic vascular disease Arterioscler. Thromb. Vasc. Biol. 24 2004 1542 1548 (Pubitemid 39180875)
26. S.A. Park, H.K. Na, and Y.J. Surh Resveratrol suppresses 4-hydroxyestradiol-induced transformation of human breast epithelial cells by blocking IkappaB kinasebeta-NF-kappaB signaling Free Radical Res. 46 2012 1051 1057
27. X. Qian, T. Yin, T. Li, C. Kang, R. Guo, B. Sun, and C. Liu High levels of inflammation and insulin resistance in obstructive sleep apnea patients with hypertension Inflammation 35 2012 1507 1511
28. Sanchez-Nino, M.D., Bozic, M., Cordoba-Lanus, E., Valcheva, P., Gracia, O., Ibarz, M., Fernandez, E., Navarro-Gonzalez, J.F., Ortiz, A., Valdivielso, J.M., 2011. Beyond proteinuria: VDR activation reduces renal inflammation in experimental diabetic nephropathy. Am. J. Physiol. Ren. Physiol. 302, F647-657.
29. M. Shakibaei, C. Buhrmann, and A. Mobasheri Resveratrol-mediated SIRT-1 interactions with p300 modulate receptor activator of NF-kappaB ligand (RANKL) activation of NF-kappaB signaling and inhibit osteoclastogenesis in bone-derived cells J. Biol. Chem. 286 2011 11492 11505
30. X.H. Shu, H. Li, Z. Sun, M.L. Wu, J.X. Ma, J.M. Wang, Q. Wang, Y. Sun, Y.S. Fu, X.Y. Chen, Q.Y. Kong, and J. Liu Identification of metabolic pattern and bioactive form of resveratrol in human medulloblastoma cells Biochem. Pharmacol. 79 2010 1516 1525
31. K. Srinivasan, B. Viswanad, L. Asrat, C.L. Kaul, and P. Ramarao Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening Pharmacol. Res. 52 2005 313 320 (Pubitemid 41175991)
32. H.C. Su, L.M. Hung, and J.K. Chen Resveratrol, a red wine antioxidant, possesses an insulin-like effect in streptozotocin-induced diabetic rats Am. J. Physiol. Endocrinol. Metab. 290 2006 E1339 E1346
33. T. Szkudelski The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas Physiol. Res. 50 2001 537 546 (Pubitemid 34087272)
34. S. Ullevig, Q. Zhao, C.F. Lee, H. Seok Kim, D. Zamora, and R. Asmis NADPH oxidase 4 mediates monocyte priming and accelerated chemotaxis induced by metabolic stress Arterioscler. Thromb. Vasc. Biol. 32 2012 415 426
35. T. Walle, F. Hsieh, M.H. DeLegge, J.E. Oatis Jr., and U.K. Walle High absorption but very low bioavailability of oral resveratrol in humans Drug Metab. Dispos. 32 2004 1377 1382 (Pubitemid 39564557)
36. J.L. Wautier, C. Zoukourian, O. Chappey, M.P. Wautier, P.J. Guillausseau, R. Cao, O. Hori, D. Stern, and A.M. Schmidt Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats J. Clin. Invest. 97 1996 238 243
37. J. Yang, C. Yan, W. Zheng, and X. Chen Proliferation inhibition of cisplatin and aquaporin 5 expression in human ovarian cancer cell CAOV3 Arch. Gynecol. Obstet. 285 2011 239 245
38. S. Yoshino, S. Hamasaki, S. Ishida, T. Kataoka, A. Yoshikawa, N. Oketani, K. Saihara, H. Ichiki, S. Kuwahata, S. Fujita, T. Takumi, I. Yoshimoto, M. Nakazaki, and C. Tei Characterization of the effect of serum bilirubin concentrations on coronary endothelial function via measurement of high-sensitivity C-reactive protein and high-density lipoprotein cholesterol Heart Vessels 28 2013 157 165
39. H. Zhang, J. Zhang, Z. Ungvari, and C. Zhang Resveratrol improves endothelial function: role of TNF{alpha} and vascular oxidative stress Arterioscler. Thromb. Vasc. Biol. 29 2009 1164 1171
40. Z. Zheng, H. Chen, H. Wang, B. Ke, B. Zheng, Q. Li, P. Li, L. Su, Q. Gu, and X. Xu Improvement of retinal vascular injury in diabetic rats by statins is associated with the inhibition of mitochondrial reactive oxygen species pathway mediated by peroxisome proliferator-activated receptor gamma coactivator 1alpha Diabetes 59 2010 2315 2325